This event has passed
Date and Location
Walid Haida
Join M-RCBG Senior Fellow Sean Doherty and Dr. Steven St. Peter for a discussion on building the T1D Fund, a pioneering venture philanthropy model that has catalyzed $1 billion in private investment for type 1 diabetes (T1D) research.
In 2015, Sean Doherty saw that decades of outstanding academic work in T1D were not leading to new cure therapies, largely because the life sciences venture capital and biotech communities weren’t investing. By founding the T1D Fund, Sean and his team harnessed impact investing to deliver vital research knowledge and networks to the private sector, dramatically changing the outlook for T1D treatments. Read more about the T1D Fund.
In this study group, Sean and Dr. St. Peter—a career life sciences venture capitalist who led investments for the Fund—will share how they brought together disease philanthropy, private capital, biotech, and pharma to drive new therapies to patients. Explore the challenges, successes, and key lessons from this model for impact investing across many fields.